S. Bookbinder

601 total citations
10 papers, 387 citations indexed

About

S. Bookbinder is a scholar working on Anesthesiology and Pain Medicine, Physiology and Pharmacology. According to data from OpenAlex, S. Bookbinder has authored 10 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Anesthesiology and Pain Medicine, 6 papers in Physiology and 3 papers in Pharmacology. Recurrent topics in S. Bookbinder's work include Pain Management and Opioid Use (6 papers), Pain Mechanisms and Treatments (6 papers) and Opioid Use Disorder Treatment (3 papers). S. Bookbinder is often cited by papers focused on Pain Management and Opioid Use (6 papers), Pain Mechanisms and Treatments (6 papers) and Opioid Use Disorder Treatment (3 papers). S. Bookbinder collaborates with scholars based in United States. S. Bookbinder's co-authors include John S. Sundy, Allen Radin, Rachel Wu, Frederick T. Murphy, H. Ralph Schumacher, Scott Mellis, Robert Terkeltaub, A. Negro‐Vilar, Richard Rauck and Richard Ghalie and has published in prestigious journals such as Annals of the Rheumatic Diseases, Journal of Pain and Clinical Therapeutics.

In The Last Decade

S. Bookbinder

10 papers receiving 363 citations

Peers

Countries citing papers authored by S. Bookbinder

Since Specialization

Citations

This map shows the geographic impact of S. Bookbinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Bookbinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Bookbinder more than expected).

Fields of papers citing papers by S. Bookbinder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Bookbinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Bookbinder. The network helps show where S. Bookbinder may publish in the future.

Co-authorship network of co-authors of S. Bookbinder

This figure shows the co-authorship network connecting the top 25 collaborators of S. Bookbinder. A scholar is included among the top collaborators of S. Bookbinder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Bookbinder. S. Bookbinder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study 2009 ·Annals of the Rheumatic Diseases ·Robert Terkeltaub, John S. Sundy, H. Ralph Schumacher, Frederick T. Murphy, S. Bookbinder, (unknown), Rachel Wu, Scott Mellis, Allen Radin	230
2	Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: A phase I, open-label, dose-escalation clinical study 2008 ·Clinical Therapeutics ·Daniel Burge, S. Bookbinder, Alan Kivitz, Roy Fleischmann, (unknown), (unknown)	19
3	A randomized, open-label, multicenter trial comparing once-a-day AVINZA® (morphine sulfate extended-release capsules) versus twice-a-day OxyContin® (oxycodone hydrochloride controlled-release tablets) for the treatment of chronic, moderate to severe low back pain: Improved physical functioning in the ACTION trial 2007 ·Journal of Opioid Management ·Richard Rauck, S. Bookbinder, (unknown), (unknown), (unknown), (unknown), A. Negro‐Vilar, Richard Ghalie	22
4	(813) 2006 ·Journal of Pain ·(unknown), S. Bookbinder, (unknown), (unknown), A. Negro‐Vilar, E.M.G.J. de Jong, (unknown)	2
5	A randomized, open-label study of once-a-day AVINZA® (morphine sulfate extended-release capsules) versus twice-a-day OxyContin® (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: The extension phase of the ACTION trial 2006 ·Journal of Opioid Management ·Richard Rauck, S. Bookbinder, (unknown), (unknown), Richard Ghalie, A. Negro‐Vilar, (unknown), (unknown)	22
6	The ACTION study: A randomized, open-label, multicenter trial comparing once-a-day extended-release morphine sulfate capsules (AVINZA®) to twice-a-day controlled-release oxycodone hydrochloride tablets (OxyContin®) for the treatment of chronic, moderate to severe low back pain 2006 ·Journal of Opioid Management ·Richard Rauck, S. Bookbinder, (unknown), (unknown), Richard Ghalie, A. Negro‐Vilar, (unknown), (unknown)	54
7	(827) 2006 ·Journal of Pain ·(unknown), S. Bookbinder, (unknown), (unknown), A. Negro‐Vilar, E.M.G.J. de Jong, (unknown)	2
8	Randomized, multi-center study of oral once-a-day AVINZA® (morphine sulfate extended-release capsules) vs. twice daily OxyContin® (oxycodone hydrochloride controlled-release) for the treatment of chronic moderate to severe low back pain 2005 ·Journal of Pain ·Ryan C. Rauck, S. Bookbinder, (unknown), (unknown), E.M.G.J. de Jong, (unknown)	2
9	Methotrexate: its use in the rheumatic diseases. 1985 ·PubMed ·S. Bookbinder, Luis R. Espinoza, Neil A. Fenske, Bernard F. Germain, Frank B. Vasey	31
10	Inhibition of catecholamine uptake by steroids in the isolated guinea pig lung. 1975 ·PubMed ·(unknown), Louis Vachon, S. Bookbinder	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact